HealthCare Global Approves Grant of 6.45 Million Stock Options Under ESOS 2026
HealthCare Global Enterprises Ltd 路 Others (Uncategorized) 路 10 Sept 2026, 12:25 am
HealthCare Global Approves Grant of 6.45 Million Stock Options Under ESOS 2026 HealthCare Global Enterprises approved the grant of 64,46,843 employee stock options on 9th Sep'26 under the HCG ESOS 2026 scheme to eligible employees of the company, its subsidiaries, and associates. Each option converts into one equity share (face value INR 10) at an exercise price of INR 495 per share. The options carry a vesting period ranging between 1 to 7 years from the grant date, with an exercise window of up to 10 years commencing after 6 years or upon a change in control event.
Original exchange filing (PDF)
More announcements from HealthCare Global Enterprises Ltd
- Please see attached the Transcript of the Earnings Call held on November 06, 2026 with the Analysts/Investors to discuss the Unaudited Financial Results (both Standalone and Consolidated) .... 路 09 Nov 2026
- This is to inform you that the Audio recording of the Earnings Call with Analysts/Investors held on November 06, 2026, to discuss the Unaudited Financial Results (Standalone and Consolidated) .... 路 07 Nov 2026
- Press Release for Unaudited Financial Results (Standalone and Consolidated) for the quarter and six months ended September 30, 2026. 路 06 Nov 2026
- Investor Presentation on the Unaudited Financial Results (Standalone and Consolidated) for the quarter and six months ended September 30, 2026. 路 06 Nov 2026
- The Nomination and Remuneration Committee of the Board of Directors of the Company, at its meeting held today, i.e., November 05, 2026, has approved grant of Employee Stock Options to eligible .... 路 06 Nov 2026
- Unaudited Financial Results for the quarter and six months ended September 30, 2026. 路 06 Nov 2026
- Healthcare Global Enterprises Limited has submitted to the Exchange, Unaudited Financial Results of the Company (Standalone and Consolidated), for the quarter and six months ended September 30, 2026. 路 06 Nov 2026
- The Company has announced the Outcome of the Board meeting held on November 05, 2026, including approval of unaudited financial results of the Company for the quarter and six months ended .... 路 06 Nov 2026
